{"collectionById":{"ae03358f-f7b8-4973-9ea0-969bc81f18d9":{"id":"ae03358f-f7b8-4973-9ea0-969bc81f18d9","name":"Regular articles","fieldSchemas":[{"id":"6690ab56-675e-4a5b-a95b-7ed858c6dd7b","name":"Title","type":"plain_text","role":"primary"},{"id":"3247e351-f412-43af-bca3-161d995c0738","name":"Slug","type":"slug","role":"slug"},{"id":"421ec6f8-afd5-458e-ace6-3c68d1b73f4a","name":"Image","type":"image"},{"id":"e9ce536b-3dec-4310-8ea9-0f0cb5cb0c37","name":"Date","type":"date"},{"id":"fd26dd7d-05a0-49ca-b0ee-a3cc8f978d13","name":"Category","type":"plain_text"},{"id":"b30d34fa-5240-4c93-af2b-ec44429f6880","name":"Description","type":"plain_text"}],"itemById":{"751f8d1a-4b21-4227-82e1-a4721b9efa72":{"id":"751f8d1a-4b21-4227-82e1-a4721b9efa72","index":"~O7","collectionId":"ae03358f-f7b8-4973-9ea0-969bc81f18d9","fields":[{"id":"0a097b61-55d5-46d6-b1b8-74f93ff286db","value":"precision-medicine-using-modular-genomics","itemId":"751f8d1a-4b21-4227-82e1-a4721b9efa72","fieldSchemaId":"3247e351-f412-43af-bca3-161d995c0738"},{"id":"55a05ce0-26ce-4bfe-a06c-70dce8d457f5","value":"2026-05-14","itemId":"751f8d1a-4b21-4227-82e1-a4721b9efa72","fieldSchemaId":"e9ce536b-3dec-4310-8ea9-0f0cb5cb0c37"},{"id":"ce7df6fa-cf01-489f-8d49-d0b624f4fe89","value":"Research","itemId":"751f8d1a-4b21-4227-82e1-a4721b9efa72","fieldSchemaId":"fd26dd7d-05a0-49ca-b0ee-a3cc8f978d13"},{"id":"22b1688b-5b98-4729-b190-10a05fcdc535","value":"{\"image\":\"e4d434d21000db5952ca90b4ded9a33367c3d424\",\"imageThumbnail\":\"fec43c3aaa89f05c8cebd9e1dcae3584ac696670\",\"originalImageHeight\":928,\"originalImageWidth\":1232,\"altText\":\"\",\"fileName\":\"anifrilamab inviting.jpg\"}","itemId":"751f8d1a-4b21-4227-82e1-a4721b9efa72","fieldSchemaId":"421ec6f8-afd5-458e-ace6-3c68d1b73f4a"},{"id":"1aa9abd9-8748-49f9-9a77-a0ee986f729e","value":"A simple look at how RNA-based testing can help uncover patterns in immune system activity and support more informed care decisions.","itemId":"751f8d1a-4b21-4227-82e1-a4721b9efa72","fieldSchemaId":"b30d34fa-5240-4c93-af2b-ec44429f6880"},{"id":"f9552f14-2e7d-4951-8cb4-e06b42de66ee","value":"Precision Medicine using Modular Genomics","itemId":"751f8d1a-4b21-4227-82e1-a4721b9efa72","fieldSchemaId":"6690ab56-675e-4a5b-a95b-7ed858c6dd7b"}]},"cdf70363-4d8e-45ef-ba24-1fc7df953ead":{"id":"cdf70363-4d8e-45ef-ba24-1fc7df953ead","index":"~O","collectionId":"ae03358f-f7b8-4973-9ea0-969bc81f18d9","fields":[{"id":"64736e88-9426-45f9-9ce2-ca8d04f2a00b","value":"{\"image\":\"3eb2007290d0ee2ca610b57cb8de129d4ee91fbe\",\"imageThumbnail\":\"3e8b7a0871d9ed9c335665d56fe2e4af62fa3310\",\"originalImageHeight\":4773,\"originalImageWidth\":8379,\"altText\":\"\",\"fileName\":\"iStock-491360572_super.jpg\"}","itemId":"cdf70363-4d8e-45ef-ba24-1fc7df953ead","fieldSchemaId":"421ec6f8-afd5-458e-ace6-3c68d1b73f4a"},{"id":"cc5359b3-be61-4bd2-91b4-e0d256ea3311","value":"IFN-1 gene signature testing represents the advancement of precision medicine beyond cancer in autoimmune disease","itemId":"cdf70363-4d8e-45ef-ba24-1fc7df953ead","fieldSchemaId":"b30d34fa-5240-4c93-af2b-ec44429f6880"},{"id":"e4c2b8dc-7668-4735-a96d-d6af6b463556","value":"DxTerity Receives New York Authorization for Type 1 Interferon (IFN-1) for Systemic Lupus Erythematosus","itemId":"cdf70363-4d8e-45ef-ba24-1fc7df953ead","fieldSchemaId":"6690ab56-675e-4a5b-a95b-7ed858c6dd7b"},{"id":"78cfa45a-6162-4921-aaec-b40e02066b18","value":"2022-05-18","itemId":"cdf70363-4d8e-45ef-ba24-1fc7df953ead","fieldSchemaId":"e9ce536b-3dec-4310-8ea9-0f0cb5cb0c37"},{"id":"80be6361-1e98-4cf1-ac7f-4a0b6fd8a807","value":"dxterity-receives-new-york-authorization-for-type-1-interferon-ifn-1-for-systemic-lupus-erythematosu","itemId":"cdf70363-4d8e-45ef-ba24-1fc7df953ead","fieldSchemaId":"3247e351-f412-43af-bca3-161d995c0738"}]},"e9941f4c-d4f1-4327-9c21-615339d0595b":{"id":"e9941f4c-d4f1-4327-9c21-615339d0595b","index":"~OO","collectionId":"ae03358f-f7b8-4973-9ea0-969bc81f18d9","fields":[{"id":"e2b0596b-b4aa-4921-b8b5-698ea0e1f11d","value":"DxTerity Receives CE Mark for DxCollect® Fingerstick Blood RNA Stabilization Device","itemId":"e9941f4c-d4f1-4327-9c21-615339d0595b","fieldSchemaId":"6690ab56-675e-4a5b-a95b-7ed858c6dd7b"},{"id":"aa442b4f-f9c1-48c8-a4a1-03a54067ce00","value":"Research","itemId":"e9941f4c-d4f1-4327-9c21-615339d0595b","fieldSchemaId":"fd26dd7d-05a0-49ca-b0ee-a3cc8f978d13"},{"id":"5dfa73b2-f89a-4642-b012-ee3969d07648","value":"2020-02-27","itemId":"e9941f4c-d4f1-4327-9c21-615339d0595b","fieldSchemaId":"e9ce536b-3dec-4310-8ea9-0f0cb5cb0c37"},{"id":"a53ea959-91a7-4b06-833e-7cc99ac8ae1b","value":"{\"image\":\"f47d74722873d53484ace1c153867532f0ea9e9e\",\"imageThumbnail\":\"d2670476229c1cabedd16be021ac57c120c3ce36\",\"originalImageHeight\":1840,\"originalImageWidth\":3842,\"altText\":\"\",\"fileName\":\"Hero_1.png\"}","itemId":"e9941f4c-d4f1-4327-9c21-615339d0595b","fieldSchemaId":"421ec6f8-afd5-458e-ace6-3c68d1b73f4a"},{"id":"8c763d13-83d1-48fc-b3ae-ebf04a580fb1","value":"Learn how patient-friendly testing can reduce barriers, improve convenience, and help people stay more connected to their health journey.","itemId":"e9941f4c-d4f1-4327-9c21-615339d0595b","fieldSchemaId":"b30d34fa-5240-4c93-af2b-ec44429f6880"},{"id":"c1afeec0-fe6c-4ffe-a852-2d6ce82a2185","value":"dxterity-seeks-to-deliver-meaningful-guidance-to-patients-and-physicians-from-the-conveinace-of-home","itemId":"e9941f4c-d4f1-4327-9c21-615339d0595b","fieldSchemaId":"3247e351-f412-43af-bca3-161d995c0738"}]}}},"c94d0566-82dc-4df5-b63f-8746938a46da":{"id":"c94d0566-82dc-4df5-b63f-8746938a46da","name":"Highlighted article","fieldSchemas":[{"id":"f7fc8c5b-ff56-4aef-a73a-481c7cc7bcb9","name":"Category","type":"plain_text"},{"id":"b75c275d-e282-4e1a-841a-992d0d66c1da","name":"Title","type":"plain_text","role":"primary"},{"id":"c942b06b-25fc-4a49-8efd-0bcdaff0ec1c","name":"Slug","type":"slug","role":"slug"},{"id":"200f29aa-6f6f-4d59-b2bf-4203c876802f","name":"Image","type":"image"},{"id":"ef193eef-561d-489f-9350-39bd897eb652","name":"Date","type":"date"},{"id":"6f2f7e7b-089a-466a-9e25-ad26df696bdb","name":"Description","type":"plain_text"}],"itemById":{"30190aa4-5121-4522-b6d4-aad83e666e9e":{"id":"30190aa4-5121-4522-b6d4-aad83e666e9e","index":"\"","collectionId":"c94d0566-82dc-4df5-b63f-8746938a46da","fields":[{"id":"57978efe-b686-4019-b47a-0818690e3828","value":"three-dxterity-abstracts-accepted-for-presentation-at-acr-convergence-2026","itemId":"30190aa4-5121-4522-b6d4-aad83e666e9e","fieldSchemaId":"c942b06b-25fc-4a49-8efd-0bcdaff0ec1c"},{"id":"3045b7a8-be6e-46cb-9a4f-940904c1a7d7","value":"Three DxTerity Abstracts Accepted for Presentation at ACR Convergence 2026","itemId":"30190aa4-5121-4522-b6d4-aad83e666e9e","fieldSchemaId":"b75c275d-e282-4e1a-841a-992d0d66c1da"},{"id":"67b5cd4e-0803-4f91-b1cb-48892e1330cb","value":"2026-09-08","itemId":"30190aa4-5121-4522-b6d4-aad83e666e9e","fieldSchemaId":"ef193eef-561d-489f-9350-39bd897eb652"},{"id":"e7ec4d64-b211-4b32-b9ca-78274895957f","value":"Studies examine the Type I interferon gene signature and a low-density granulocyte neutrophil signature as tools for identifying lupus patients with severe disease, inadequate response to standard of care, and signs of resistance to anifrolumab therapy","itemId":"30190aa4-5121-4522-b6d4-aad83e666e9e","fieldSchemaId":"6f2f7e7b-089a-466a-9e25-ad26df696bdb"},{"id":"40c0253c-d055-4047-a053-30b647e19d02","value":"Company","itemId":"30190aa4-5121-4522-b6d4-aad83e666e9e","fieldSchemaId":"f7fc8c5b-ff56-4aef-a73a-481c7cc7bcb9"},{"id":"4781700c-c6b4-46f0-bab7-d9afa82e52b1","value":"{\"image\":\"c5538f42bacbd9089b018862331b6333bc5af9d8\",\"imageThumbnail\":\"8348e23498678bc67f790e97f35c48917bc58359\",\"originalImageHeight\":941,\"originalImageWidth\":1672,\"altText\":\"\",\"fileName\":\"Focused Research in a Modern Laboratory.png\"}","itemId":"30190aa4-5121-4522-b6d4-aad83e666e9e","fieldSchemaId":"200f29aa-6f6f-4d59-b2bf-4203c876802f"}]},"7146f193-b365-4288-915c-f0a008c2af6d":{"id":"7146f193-b365-4288-915c-f0a008c2af6d","index":"#","collectionId":"c94d0566-82dc-4df5-b63f-8746938a46da","fields":[{"id":"b6943b21-c105-4da7-b389-c448abebe24d","value":"Company","itemId":"7146f193-b365-4288-915c-f0a008c2af6d","fieldSchemaId":"f7fc8c5b-ff56-4aef-a73a-481c7cc7bcb9"},{"id":"0d9abd17-91d5-4acf-b1e4-15d4f0008362","value":"dxterity-opens-purpose-built-torrance-headquarters-and-laboratory","itemId":"7146f193-b365-4288-915c-f0a008c2af6d","fieldSchemaId":"c942b06b-25fc-4a49-8efd-0bcdaff0ec1c"},{"id":"5bfcf64b-34c4-4885-9726-bc1aa37985e5","value":"DxTerity Opens Purpose-Built Torrance Headquarters and Laboratory","itemId":"7146f193-b365-4288-915c-f0a008c2af6d","fieldSchemaId":"b75c275d-e282-4e1a-841a-992d0d66c1da"},{"id":"9cf588d4-0e3a-4e85-962d-adf98cfc7579","value":"{\"image\":\"dcc6c1d33dea3f12de00944c98845bdd4011dc40\",\"imageThumbnail\":\"7140d1a1adf658b1ffa5a32953117b874b0ead29\",\"originalImageHeight\":1088,\"originalImageWidth\":1445,\"altText\":\"\",\"fileName\":\"Modern Office Exterior at 2848.png\"}","itemId":"7146f193-b365-4288-915c-f0a008c2af6d","fieldSchemaId":"200f29aa-6f6f-4d59-b2bf-4203c876802f"},{"id":"18df4b5e-1770-4322-9f7f-d3e42fa3f53f","value":"2026-09-08","itemId":"7146f193-b365-4288-915c-f0a008c2af6d","fieldSchemaId":"ef193eef-561d-489f-9350-39bd897eb652"},{"id":"4f0f2099-9104-4895-beb4-fe248317cdcf","value":"DxTerity opens a purpose-built headquarters and clinical laboratory in Torrance, California, to support growing demand for its RNA-based genomic testing.","itemId":"7146f193-b365-4288-915c-f0a008c2af6d","fieldSchemaId":"6f2f7e7b-089a-466a-9e25-ad26df696bdb"}]}}}},"slugByItemId":{"e9941f4c-d4f1-4327-9c21-615339d0595b":"dxterity-seeks-to-deliver-meaningful-guidance-to-patients-and-physicians-from-the-conveinace-of-home","751f8d1a-4b21-4227-82e1-a4721b9efa72":"precision-medicine-using-modular-genomics","cdf70363-4d8e-45ef-ba24-1fc7df953ead":"dxterity-receives-new-york-authorization-for-type-1-interferon-ifn-1-for-systemic-lupus-erythematosu","e63e79ef-9384-494b-a3dc-bda6a026ebb5":"the-landmark-study-is-targeting-the-prospective-enrollment-of-up-to-3500-adults-diagnosed-with-syste","30190aa4-5121-4522-b6d4-aad83e666e9e":"three-dxterity-abstracts-accepted-for-presentation-at-acr-convergence-2026","7146f193-b365-4288-915c-f0a008c2af6d":"dxterity-opens-purpose-built-torrance-headquarters-and-laboratory"}}